Price of EXEL with the Market Cap of BBIO

If Exelixis, Inc. (EXEL) had the market cap of BridgeBio Pharma, Inc. (BBIO), one EXEL would cost $63.19, 9.52% less than today's price of $69.84. The market cap of Exelixis, Inc. ($17.23B) is 1.11 times that of BridgeBio Pharma, Inc. ($15.59B).

Result

With The Market Cap of

$63.19
(0.90x)

EXEL is 1.11x above BBIO

EXEL.US Market Cap
EXEL.US M. Cap:
$17,233,439,040
BBIO.US Market Cap
BBIO.US M. Cap:
$15,592,214,349
Wonder your profit?
Estimated value:
$0.00
EXEL
EXEL is 1.11x above BBIO
EXEL.US Market Cap
EXEL.US M. Cap:
$17,233,439,040
BBIO.US Market Cap
BBIO.US M. Cap:
$15,592,214,349

Stock data: Financial Modeling Prep·Updated ·Not investment advice·How we calculate this

Exelixis, Inc. vs BridgeBio Pharma, Inc.: key figures

Exelixis, Inc. EXEL BridgeBio Pharma, Inc. BBIO
Rank #1307 #1420
Price $69.84 $79.54
Market cap $17.23B $15.59B
Shares Outstanding 246.76M 196.03M
Change (1 day) -1.22% +1.11%
Change (1 year) +64.91% +22.26%

The other way round: BBIO with the market cap of EXEL

$87.91 (1.11x)

If BridgeBio Pharma, Inc. (BBIO) had the market cap of Exelixis, Inc. (EXEL), one BBIO would cost $87.91, 1.11 times today's price of $79.54.

Price of BBIO with the Market Cap of EXEL

Price of EXEL with the Market Cap of BBIO: the last 12 months

The price of one EXEL if Exelixis, Inc. had the market cap of BridgeBio Pharma, Inc., at the end of each month. Highest: $63.19 (Nov 2026). Lowest: $48.28 (Feb 2026).

  1. $54.29 Dec 2025
  2. $54.84 Jan 2026
  3. $48.28 Feb 2026
  4. $53.93 Mar 2026
  5. $51.65 Apr 2026
  6. $49.96 May 2026
  7. $56.16 Jun 2026
  8. $62.91 Jul 2026
  9. $59.68 Aug 2026
  10. $51.27 Sep 2026
  11. $58.09 Oct 2026
  12. $63.19 Nov 2026

Questions about Exelixis, Inc. and BridgeBio Pharma, Inc.

What would the price of Exelixis, Inc. be with the market cap of BridgeBio Pharma, Inc.?

If Exelixis, Inc. (EXEL) had the market cap of BridgeBio Pharma, Inc. (BBIO), one EXEL would cost $63.19, 9.52% less than today's price of $69.84.

How much bigger is Exelixis, Inc. than BridgeBio Pharma, Inc.?

The market cap of Exelixis, Inc. ($17.23B) is 1.11 times that of BridgeBio Pharma, Inc. ($15.59B). In Dec 2025 it was the other way round: BridgeBio Pharma, Inc. was 1.24 times bigger than Exelixis, Inc..

What would the price of BridgeBio Pharma, Inc. be with the market cap of Exelixis, Inc.?

If BridgeBio Pharma, Inc. (BBIO) had the market cap of Exelixis, Inc. (EXEL), one BBIO would cost $87.91, 1.11 times today's price of $79.54.

How is this price calculated?

The market cap of BridgeBio Pharma, Inc. ($15.59B) is divided by the number of EXEL in circulation (246.76M). Market cap is the price multiplied by the number of coins or shares in circulation.